Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
about
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept studyThe Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors.Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients.Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
P2860
Q34487408-5FC1F272-E133-4274-B60F-0B45152F9459Q36545617-0AEC6363-F7B1-491D-BB41-158D3B52BA03Q37730059-062BBF07-078C-45C4-BAE0-E6662F70B114Q38416371-D1DF71CD-C244-42C9-9534-7EF9A7B42BD7Q39283573-D02090FA-99C1-440A-B83F-73BE8FF1DAFBQ42219821-2443B1E8-241D-45BA-B363-54BB44C8C625Q44884259-834C685F-CC32-4D4A-8F4B-0E3DA6FF33C8Q45187719-0AB21973-B5C1-4EAF-A23A-1100DE88644EQ52814358-62952FD8-CF62-48C2-83CC-D10ACD7B07B8Q54340634-2F3E408D-E70F-48E0-A99F-488125E909D5
P2860
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@en
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@nl
type
label
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@en
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@nl
prefLabel
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@en
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@nl
P2093
P2860
P356
P1433
P1476
Effect of graft-versus-host di ...... yclosporin A and methotrexate.
@en
P2093
Furukawa T
Hamajima N
Hirabayashi N
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403343
P577
2004-05-01T00:00:00Z
P5875
P6179
1034199655